CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 129 enrolled
Drug / intervention
AcQMap Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02825992
NCT02825992N/ACompleted
CompareCT.gov

Utilizing Novel Dipole Density Capabilities to Objectively Visualize the Etiology of Rhythms in Atrial Fibrillation (UNCOVER-AF)

Acutus Medical·interventional·Posted Jul 7, 2016·Updated Jun 5, 2020

In Brief

A clinical study evaluating AcQMap System for Persistent Atrial Fibrillation. Completed, enrolled 129 participants across 12 sites in 6 countries.

Detailed Summary

A prospective, single-arm, multi-center, multi-national, non-randomized, post-market study designed to provide clinical data regarding the use of the AcQMap™ System in the ablation of persistent atrial fibrillation. (CL-AF-002 - EU) A prospective, single-arm, multi-center, multi-national non-randomized study designed to provide clinical data regarding the use of the AcQMap™ System in the ablation of persistent atrial fibrillation. (CL-AF-001 - Canadian)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPersistent Atrial Fibrillation
CountriesCanada, Czechia, Germany, Italy, Netherlands, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 7, 2016
Enrollment StartOct 17, 2016
Primary CompletionApr 30, 2017
Study CompletionMay 15, 2018
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.0 years ago

Interventions

AcQMap Systemdevice

3D imaging and mapping system for cardiac chambers